Prevention

Researchers have identified multiple evidence-based strategies for improving suicide prevention, according to results of a systematic review published in American Journal of Psychiatry.

Many adults aged at least 75 years are taking aspirin for primary CVD prevention despite lack of evidence, whereas many are not taking statins for primary CVD prevention despite strong evidence, researchers reported.

Cholesterol testing dropped during the COVID-19 pandemic, raising concerns about providing patients with proper preventive care, according to a study published in the American Journal of Preventive Cardiology.

Coffee and green tea consumption may be beneficial for CVD prevention, according to study data published in Stroke.

Oral prednisone led to a greater decrease in the number of episodic cluster headaches within the first week of treatment vs. placebo, according to findings from a multicenter trial published in The Lancet Neurology.

From 2008 to 2017, overall rates of recurrent MI declined among men and women in the U.S. in the 365 days after discharge, according to research published in Circulation.

The CV benefits of BP lowering, for both primary and secondary prevention, were found to be proportional to the intensity of the reduction regardless of baseline BP, researchers reported.

In patients with chronic coronary disease, adding low-dose colchicine to optimal medical therapy reduced risk for CV events by 31%, according to results of the LoDoCo2 trial presented at the European Society of Cardiology Congress.

Significant disparities persist regarding secondary prevention for CHD, particularly for treatment, risk factor control and medical therapy adherence, researchers found.

The Million Hearts initiative utilizes evidence-based approaches to reduce MIs and strokes in the U.S., according to a presentation at the virtual American Society for Preventive Cardiology Congress on CVD Prevention.